GlassScriptPhysician profile
Tania Yousaf
NPI 1326555921
$523.06
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.65 · 2022: $96.99 · 2023: $89.83 · 2024: $101 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $153.78 | 2023-2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Ferring Pharmaceuticals INC. | $146.17 | 2023-2025 | Menopur |
| Coopersurgical, INC. | $45.47 | 2023-2025 | Stripper |
| Scynexis, INC. | $30.45 | 2022 | |
| Astellas Pharma US INC | $27.80 | 2021 | |
| Mayne Pharma Commercial LLC | $24.30 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.91 | 2022 | |
| Evofem Biosciences, INC. | $19.54 | 2021 | |
| Hologic Sales and Service, LLC | $18.33 | 2022 | |
| Myovant Sciences INC. | $18.14 | 2021 | |
| Amgen INC. | $15.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Yousaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.